Latest News

The procedure used advanced digital infrastructure and high-reliability communications technology to connect medical teams at the two facilities, enabling specialists to perform surgery remotely despite the geographical distance between the sites.

The partnerships will enable healthcare providers to integrate wearable and out-of-hospital monitoring technologies into the Philips ecosystem.

The study is designed to provide confirmatory evidence for lacutamab in two CTCL subtypes, Sézary syndrome and mycosis fungoides, potentially supporting full regulatory approval.

Vanflyta received approval in China in June 2026 for use in adults with newly diagnosed FLT3-ITD-positive AML, as determined by an appropriate validated diagnostic test.

Health Minister Khaled Abdel Ghaffar discussed the proposed fund and potential areas of cooperation with representatives of Gold Rock Venture during a meeting at the ministry’s headquarters in New Alamein.

The centerpiece of the deal is gildeuretinol, formerly known as ALK-001, a once-daily oral therapy under development for Stargardt disease, a rare inherited retinal disorder.

The approval expands Orzeyful’s commercial reach following its authorization in China in July 2026, marking another milestone in Takeda’s global launch strategy.

Under the agreement, Ono will work with Mediar to identify potential treatments using the biotechnology company’s fibrosis-focused discovery platform and expertise in myofibroblast biology and fibrosis-related pathways.

Keyhole surgery, also known as minimally invasive surgery, involves making small incisions through which surgeons insert specialized instruments and a camera to perform an operation.

Under the four-year agreement, Novartis India had granted Dr Reddy’s an exclusive and non-transferable right to promote, distribute and sell certain products in the Indian market.